Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Photocure ASA

Market Cap 1.54B 162M 140M 129M 121M 227M 15.49B 231M 1.54B 598M 7.47B 607M 594M 25.96B P/E Ratio 2026 *
19x
P/E Ratio 2027 * 30.2x
Enterprise Value 1.22B 128M 111M 102M 95.82M 179M 12.24B 183M 1.22B 472M 5.9B 480M 470M 20.52B EV / Sales 2026 *
1.92x
EV / Sales 2027 * 1.74x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day-0.64%
1 week-16.37%
Current month-16.37%
1 month-12.59%
3 months-11.71%
6 months+10.75%
Current year-11.71%
1 week 6.18
Extreme 6.18
6.73
1 month 6.18
Extreme 6.18
6.73
Current year 6.18
Extreme 6.18
7.39
1 year 5.15
Extreme 5.15
7.39
3 years 4.32
Extreme 4.32
7.39
5 years 4.21
Extreme 4.21
17.57
10 years 3
Extreme 3
17.57
Manager TitleAgeSince
Chief Executive Officer - 01/11/2018
Chief Executive Officer - 01/07/2018
Chief Tech/Sci/R&D Officer - 01/08/2021
Director TitleAgeSince
Director/Board Member - 01/01/2022
Chairman - 27/09/2023
Director/Board Member - 23/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-0.64%-16.37% - - 162M
+2.16%+3.17%+43.57%+160.28% 1,035B
-0.07%+4.45%+53.50%+48.95% 574B
-0.08%-0.08%+17.37%+62.66% 397B
+0.77%+0.77%+21.19%+15.95% 324B
+0.85%+0.18%+24.50%+15.93% 281B
+2.10%+4.92%+25.30%+34.79% 278B
-0.19%-0.46%-45.32%-48.23% 193B
+4.84%+2.45%+21.33%+61.85% 191B
+3.61%-2.56%+15.16%+61.12% 156B
Average +1.33%+1.68%+19.62%+45.92% 381.1B
Weighted average by Cap. +1.37%+2.39%+29.50%+72.97%

Financials

2026 *2027 *
Net sales 634M 66.62M 57.81M 53.29M 49.93M 93.3M 6.38B 95.24M 636M 246M 3.07B 250M 245M 10.69B 676M 70.93M 61.55M 56.73M 53.16M 99.33M 6.79B 101M 677M 262M 3.27B 266M 261M 11.38B
Net income 81.5M 8.56M 7.43M 6.85M 6.41M 11.98M 819M 12.23M 81.65M 31.61M 395M 32.12M 31.43M 1.37B 51M 5.35M 4.65M 4.28M 4.01M 7.5M 513M 7.66M 51.1M 19.78M 247M 20.1M 19.67M 859M
Net Debt -323M -33.91M -29.43M -27.13M -25.42M -47.49M -3.25B -48.48M -324M -125M -1.57B -127M -125M -5.44B -365M -38.32M -33.26M -30.66M -28.72M -53.67M -3.67B -54.79M -366M -142M -1.77B -144M -141M -6.15B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
08/06/26 6.180 $ -0.64% 3,650
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
57.90NOK
Average target price
85.00NOK
Spread / Average Target
+46.80%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!